Statistics for Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer
Total visits
views | |
---|---|
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer | 251 |
Total visits per month
views | |
---|---|
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
File Visits
views | |
---|---|
JCO.2017.72.4138.pdf | 220 |
Top country views
views | |
---|---|
United States | 190 |
Germany | 15 |
Sweden | 7 |
China | 5 |
Ukraine | 5 |
Canada | 2 |
United Kingdom | 1 |
Greece | 1 |
Iran | 1 |
Malaysia | 1 |
Russia | 1 |
Top city views
views | |
---|---|
Wilmington | 55 |
Fairfield | 25 |
Houston | 16 |
Kiez | 11 |
White Plains | 10 |
Ann Arbor | 7 |
Jacksonville | 7 |
Cambridge | 6 |
Indianapolis | 6 |
Stockholm | 6 |
Kiev | 5 |
Gunzenhausen | 4 |
Ling | 4 |
Seattle | 3 |
Washington | 3 |
Brooklyn | 2 |
Lake Mary | 2 |
Toronto | 2 |
Beijing | 1 |
Chestertown | 1 |
Chicago | 1 |
Monmouth Junction | 1 |
Mountain View | 1 |
Philadelphia | 1 |
Péfki | 1 |
Saint Petersburg | 1 |
San Francisco | 1 |
Scottsdale | 1 |
Seremban | 1 |
Tehran | 1 |